Use of glycopyrrolate in the treatment of meniere's disease

  title={Use of glycopyrrolate in the treatment of meniere's disease},
  author={I. Storper and J. Spitzer and M. Scanlan},
  journal={The Laryngoscope},
Objectives/Hypothesis: The objective of this study was to determine whether glycopyrrolate is useful as a vestibular suppressant in patients with Meniere's disease. The tested hypotheses were that glycopyrrolate would decrease the perception of dizziness measured by the Dizziness Handicap Inventory in patients with Meniere's disease and that placebo would cause no such decrease. Study Design: Randomized, prospective. Methods: Thirty‐seven subjects with a diagnosis of Meniere's disease were… Expand
25 Citations
Depression in Ménière's disease: a systematic review and meta-analysis.
  • 1
Pharmacological Treatment of Vertigo
  • 106
Clinical Practice Guideline: Ménière’s Disease
  • G. Basura, M. Adams, +20 authors E. Buchanan
  • Medicine
  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2020
  • 14
A Review of Medical Treatment for Ménière's Disease
  • J. Claes
  • Medicine
  • Acta oto-laryngologica. Supplementum
  • 2000
  • 70
Nocebo Effect in Menière's Disease: A Meta-analysis of Placebo-controlled Randomized Controlled Trials.
  • P. A. Dimitriadis, P. Zis
  • Medicine
  • Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2017
  • 8
Meniere's disease in Finland. An epidemiological and clinical study on occurrence, clinical picture and policy.
  • 7
  • PDF
Pharmacologic treatment of persons with dizziness.
  • 44
Manual therapy for cervicogenic dizziness: Long-term outcomes of a randomised trial.
  • 26
  • PDF


Development of the Tinnitus Handicap Inventory.
  • 1,268
The development of the Dizziness Handicap Inventory.
  • 1,381
Medical Management of Meniere's Disease
  • 34
Glycopyrrolate methobromide
  • 36
  • PDF
Clinical neurophysiology of the vestibular system.
  • 521
  • PDF
Ondansetron and related 5-HT3 antagonists: recent advances.
  • 26
For information contact the Administrative a n d Scientific Secretariat, SOCWMeniere '99; 14, rue Mandar, 75002 Paris
  • The deadline for advance registration is February 10
  • 1998
Pharmacotherapy of vestibular dysfunction
  • Jackler RK, Brackmann DE, eds. Neurotology. Baltimore: Mosby,
  • 1994